FTSE 100 moves higher but Halfords leads retailers lower on outlook fears
Analysts at UBS point to cautious consumer environment and Amazon worriesLeading shares are edging higher despite a fall in the oil price and renewed fears that the UK may vote to leave the European...
View ArticleEasyJet slips after update but Shire climbs as deal concerns fade
Shire recovers as analysts say US tax rules should not affect Baxalta planAs markets recover some ground following better than expected Chinese data and a revival in the oil price, easyJet shares have...
View ArticleExecutive pay: Shareholder revolts at Weir and Shire- as it happened
Shareholder revolts gather paceWeir Group voted down on pay policySchroders shareholders vent frustrationShire investors fail to support chief executive’s riseEarlier:US GDP shows sharp...
View ArticleShire and Weir bosses feel sting of investor ire as pay revolts widen
Drug maker and engineer not alone on day shareholders use AGMs to protest en masse against boardroom bonuses and payBoardroom bosses have received stinging rebukes over pay, with the engineering group...
View ArticleThree more companies face shareholder wrath over executive pay
Investors revolt over pay at AGMs of Ladbrokes, Reckitt Benckiser and Carillion, following rebellions at BP, Shire and othersThree more big UK companies have suffered damaging investor revolts over...
View ArticleShire climbs on prospects for Baxalta merger
Analysts positive about deal which is due to complete by end of weekOn a downbeat day, shares in Shire are bucking the trend.The pharmaceutical group’s shares have climbed 105p or 2.4% to £43.65 after...
View ArticleTop FTSE 100 bosses landed pay rises of nearly £100m in 2015
Biggest percentage rise reserved for Berkeley’s Tony Pidgley, while Sir Martin Sorrell won the largest rise in money terms Ten FTSE 100 leaders enjoyed combined pay rises worth nearly £100m last year,...
View ArticleOld Mutual falls after results while Shire slips on deal talk
Insurer disappoints investors as it warns of uncertain environmentLeading shares have recovered some of their early losses but are still in negative territory, mainly due to the number of companies...
View ArticlePharmaceutical shares fall on Clinton comments on excessive drug prices
Drugs companies among biggest FTSE fallers after threatened clampdownPharmaceutical shares have come under pressure after new comments from US presidential candidate Hillary Clinton about excessive...
View ArticleShire shares fall after reporting drop in sales of haemophilia drugs
London-listed company’s third-quarter results disappoint City, as investors also worry about future pricing in the USThe pharmaceutical company Shire has reported a drop in sales of haemophilia drugs,...
View ArticleFTSE 100 edges higher with Shire benefitting from a problem at rival Roche
Comparison site Gocompare steady in first day of dealingsLeading shares are moving higher after their recent slide to a six week low, ahead of the latest interest rate decision from the Bank of...
View ArticleBrexit: the price of post-truth pounds in our pockets
Fifty years after Harold Wilson’s speech, people are still talking a load of nonsense about sterlingThis year marks the 50th anniversary of Harold Wilson’s memorable broadcast following his...
View ArticleShire's shares surge as Japan's Takeda considers bid
UK-listed drugmaker, known for ADHD treatment Adderall, is valued at more than £30bnShares in the UK-listed drugmaker Shire surged after Japan’s biggest pharmaceutical company, Takeda Pharmaceutical,...
View ArticleReckitt Benckiser needs to wean itself off a dud pay model | Nils Pratley
When a scheme for calculating exec pay can’t stand the lightest brush with common sense, it’s time for changeShed no tears for Rakesh Kapoor, the chief executive of Reckitt Benckiser who has had £11.2m...
View ArticleShire rebuffs Takeda takeover bid as Allergan drops out
Shire shares rise after Allergan said it was considering making an offer for maker of ADHD medicine Adderall Nils Pratley: Shire saga smells of overadventurous engineeringThe drugs company Shire is at...
View ArticleShire saga smells of overadventurous engineering | Nils Pratley
It is not obvious that Takeda or Allergan can make the takeover numbers workRoll up, roll up, who wants to buy Shire? The FTSE 100 pharmaceutical company, itself built by acquisitions, is suddenly in...
View ArticleShire board recommends £46bn takeover by Japanese drugmaker Takeda
Deal for the FTSE100 company and maker of ADHD drug will be one of the biggest everThe UK-listed drugmaker Shire, known for its ADHD hyperactivity drug Adderall, has recommended a £46bn takeover deal...
View ArticleAdderall maker Shire agrees £46bn takeover by Takeda
Japanese drugmaker increases offer to secure biggest deal since 2000 in pharmaceutical sectorShire, the London-listed maker of treatments for ADHD and rare diseases, has finally agreed to a takeover by...
View ArticleUK house prices fall; Takeover drama at Shire and Virgin Money - as it happened
All the day’s economic and financial news, including the latest on two takeover dealsHalifax: UK house prices down 3.1% (!) in AprilJapan’s Takeda has agreed to buy FTSE-100 listed ShireShire shares...
View ArticleChallenger banks discover they won't get far on their own | Nils Pratley
Virgin Money’s deal with CYBG makes commercial logic but it won’t reshape the banking sector So much for the post-crisis idea that the UK’s big four banks would be knocked off their comfortable perches...
View Article
